Sign up to save your podcasts
Or
Share 314: JD Vance's biotech ties, Cassava resignations, and insulin shortages
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
314: JD Vance's biotech ties, Cassava resignations, and insulin shortages
Our Washington correspondent Sarah Owermohle joins us to talk about how JD Vance, Donald Trump's newly announced running mate, could influence health policy if Trump wins the election. We also discuss the latest news in the biopharma industry, including the latest developments in the ongoing controversy surrounding Cassava’s Alzheimer’s drug, shortages of insulin as Novo Nordisk and Eli Lilly turn their focus toward GLP-1 drugs, and a shakeup in leadership at Gilead.
View all episodes
By STAT
4.5
303303 ratings
Our Washington correspondent Sarah Owermohle joins us to talk about how JD Vance, Donald Trump's newly announced running mate, could influence health policy if Trump wins the election. We also discuss the latest news in the biopharma industry, including the latest developments in the ongoing controversy surrounding Cassava’s Alzheimer’s drug, shortages of insulin as Novo Nordisk and Eli Lilly turn their focus toward GLP-1 drugs, and a shakeup in leadership at Gilead.
More shows like The Readout Loud
View all
Planet Money
30,974 Listeners
a16z Podcast
1,014 Listeners
Odd Lots
1,774 Listeners
How I Built This with Guy Raz
30,265 Listeners
The Daily
111,044 Listeners
KFF Health News' 'What the Health?'
482 Listeners
The Long Run with Luke Timmerman
123 Listeners
Tradeoffs
386 Listeners
Biotech 2050 Podcast
60 Listeners
Business Of Biotech
88 Listeners
BioCentury This Week
31 Listeners
Raising Health
146 Listeners
Biotech Hangout
11 Listeners
Ground Truths
45 Listeners
Money Stuff: The Podcast
368 Listeners